Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Nalena vs Ro

Nalena
Graded #98

Lower grade

vs+9
Ro
Graded #38

Higher grade

The verdict

Ro takes it — 80.2/100 to 71.2/100.

Ro grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNalena +6
74
68
Dose & formulationRo +22
64
86
Clinical oversightRo +4
82
86
Labs & monitoringRo +29
53
82
FulfillmentNalena +5
89
84
Contract termsRo +19
61
80
Nalena · left barRo · right bar

The numbers

MetricNalenaRo
WeighScore71.2/10080.2/100
GradeCB−
Scorecard rank#98#38
Semaglutide$149/mo (starting dose, compounded)Not disclosed
Tirzepatide$149/mo (starting dose, compounded)Not disclosed
CoverageAll 50 statesMulti-state
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Nalena

Graded #98 · C

Strengths

  • Compounded GLP-1 from $149/mo with medication included — near the floor of the compounded market
  • Transparent fee model: no hidden fees, no membership, cancel anytime
  • Money-back guarantee — uncommon among compounded telehealths
  • Clinical provider disclosed: Beluga Health, P.A. in Houston, TX
  • Women-focused positioning

Where it loses points

  • Per-dose pricing not published — only the 'starting at $149' entry price
  • No LegitScript, HIPAA, or NABP badges on public pages
  • Compounding pharmacy partners not named (only 'multiple USA certified pharmacies')
  • Houston address looks like a virtual office rather than a clinical facility
  • No brand-name GLP-1s (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded only
Ro

Graded #38 · B−

Strengths

  • Brand-name access + insurance support
  • Oral options
  • Well-funded platform

Where it loses points

  • Does not disclose compounded pricing up front
  • Premium positioning

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard